Lasa Supergenerics Ltd vs Zenlabs Ethica Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Lasa Supergenerics Ltd is ₹ 8.2 as of 08 May 11:58 . The P/E Ratio of Lasa Supergenerics Ltd changed from 10.7 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 17.9 on March 2021 to 76.1 on March 2025 . This represents a CAGR of 33.57% over 5 years The Market Cap of Lasa Supergenerics Ltd changed from ₹ 243.63 crore on March 2021 to ₹ 84.42 crore on March 2025 . This represents a CAGR of -19.10% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 13.77 crore on March 2021 to ₹ 20.32 crore on March 2025 . This represents a CAGR of 8.09% over 5 years The revenue of Lasa Supergenerics Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 revenue of ₹ 3.07 crore. This represent the decline of -27.69% The revenue of Zenlabs Ethica Ltd for the Dec '25 is ₹ 12.43 crore as compare to the Sep '25 revenue of ₹ 12.49 crore. This represent the decline of -0.48% The ebitda of Lasa Supergenerics Ltd for the Dec '25 is ₹ -0.73 crore as compare to the Sep '25 ebitda of ₹ -3.99 crore. This represent the decline of -81.7% The ebitda of Zenlabs Ethica Ltd for the Dec '25 is ₹ -1.56 crore as compare to the Sep '25 ebitda of ₹ 0.51 crore. This represent the decline of -405% The net profit of Lasa Supergenerics Ltd changed from ₹ -2.73 crore to ₹ -2.55 crore over 7 quarters. This represents a CAGR of -3.82% The net profit of Zenlabs Ethica Ltd changed from ₹ 0.04 crore to ₹ -2.01 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016.
The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

About Zenlabs Ethica Ltd

Zenlabs Ethica Limited was initially incorporated in the name of Neelkanth Technologies Limited on 20 July, 1993.
With the due approval from the Registrar of Companies, Ministry of Corporate Affairs, name of the Company was changed to Zenlabs Ethica Limited in 2016-17. The Company is one of the top 10 pharmaceutical contract manufacturing companies in India that develops, markets and exports a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti Hypertensive Drugs, Anti-Infective, Soaps & Anti Bacterial Drugs, Nutraceuticals, etc.
The company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
It offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India. In 2023, the Company ventured into diversified segments like Neurology and Cytrics.

FAQs for the comparison of Lasa Supergenerics Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Lasa Supergenerics Ltd or Zenlabs Ethica Ltd?

Market cap of Lasa Supergenerics Ltd is 40 Cr while Market cap of Zenlabs Ethica Ltd is 16 Cr

What are the key factors driving the stock performance of Lasa Supergenerics Ltd and Zenlabs Ethica Ltd?

The stock performance of Lasa Supergenerics Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lasa Supergenerics Ltd and Zenlabs Ethica Ltd?

As of May 8, 2026, the Lasa Supergenerics Ltd stock price is INR ₹8.15. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹25.22.

How do dividend payouts of Lasa Supergenerics Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Lasa Supergenerics Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.